When to implement a commercial patient access programme

Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product.

Dane will be presenting at the Pre-Approval Access Programs this September 25-27th in Philadelphia, PA. 

Download the article via the button below